nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—Retinoids—Isotretinoin—peripheral nervous system neoplasm	0.174	0.569	CiPCiCtD
Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.15	0.569	CrCtD
Tretinoin—Retinoids—Alitretinoin—peripheral nervous system neoplasm	0.132	0.431	CiPCiCtD
Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.114	0.431	CrCtD
Tretinoin—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.0324	0.19	CrCrCtD
Tretinoin—Acitretin—Isotretinoin—peripheral nervous system neoplasm	0.0324	0.19	CrCrCtD
Tretinoin—Vitamin A—Isotretinoin—peripheral nervous system neoplasm	0.0324	0.19	CrCrCtD
Tretinoin—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.0245	0.144	CrCrCtD
Tretinoin—Vitamin A—Alitretinoin—peripheral nervous system neoplasm	0.0245	0.144	CrCrCtD
Tretinoin—Acitretin—Alitretinoin—peripheral nervous system neoplasm	0.0245	0.144	CrCrCtD
Tretinoin—CRABP1—Alitretinoin—peripheral nervous system neoplasm	0.0226	0.117	CbGbCtD
Tretinoin—CRABP2—Alitretinoin—peripheral nervous system neoplasm	0.0226	0.117	CbGbCtD
Tretinoin—RARG—Isotretinoin—peripheral nervous system neoplasm	0.0152	0.0787	CbGbCtD
Tretinoin—RXRG—Isotretinoin—peripheral nervous system neoplasm	0.0152	0.0787	CbGbCtD
Tretinoin—RXRB—Isotretinoin—peripheral nervous system neoplasm	0.0134	0.0695	CbGbCtD
Tretinoin—RXRA—Isotretinoin—peripheral nervous system neoplasm	0.0134	0.0695	CbGbCtD
Tretinoin—RARB—Isotretinoin—peripheral nervous system neoplasm	0.0134	0.0695	CbGbCtD
Tretinoin—RARA—Isotretinoin—peripheral nervous system neoplasm	0.0134	0.0695	CbGbCtD
Tretinoin—RARG—Alitretinoin—peripheral nervous system neoplasm	0.00937	0.0486	CbGbCtD
Tretinoin—RXRG—Alitretinoin—peripheral nervous system neoplasm	0.00937	0.0486	CbGbCtD
Tretinoin—RARB—Alitretinoin—peripheral nervous system neoplasm	0.00828	0.043	CbGbCtD
Tretinoin—RXRB—Alitretinoin—peripheral nervous system neoplasm	0.00828	0.043	CbGbCtD
Tretinoin—RXRA—Alitretinoin—peripheral nervous system neoplasm	0.00828	0.043	CbGbCtD
Tretinoin—RARA—Alitretinoin—peripheral nervous system neoplasm	0.00828	0.043	CbGbCtD
Tretinoin—NR0B1—Vincristine—peripheral nervous system neoplasm	0.00553	0.0287	CbGbCtD
Tretinoin—CYP4A11—Cisplatin—peripheral nervous system neoplasm	0.00248	0.0129	CbGbCtD
Tretinoin—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.000907	0.0047	CbGbCtD
Tretinoin—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.000387	0.00201	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.000387	0.00201	CbGbCtD
Tretinoin—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.000344	0.00179	CbGbCtD
Tretinoin—RXRA—ganglion—peripheral nervous system neoplasm	0.000311	0.113	CbGeAlD
Tretinoin—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.000291	0.00151	CbGbCtD
Tretinoin—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.000266	0.00138	CbGbCtD
Tretinoin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.000265	0.00138	CbGbCtD
Tretinoin—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.000256	0.00133	CbGbCtD
Tretinoin—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.0012	CbGbCtD
Tretinoin—RARRES1—trigeminal ganglion—peripheral nervous system neoplasm	0.000229	0.0831	CbGeAlD
Tretinoin—RARG—tongue—peripheral nervous system neoplasm	0.000226	0.0817	CbGeAlD
Tretinoin—RARRES1—parotid gland—peripheral nervous system neoplasm	0.000216	0.0783	CbGeAlD
Tretinoin—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.000182	0.000943	CbGbCtD
Tretinoin—ALDH1A1—Teniposide—Etoposide—peripheral nervous system neoplasm	0.000176	0.271	CbGdCrCtD
Tretinoin—ALDH1A1—Podofilox—Etoposide—peripheral nervous system neoplasm	0.000176	0.271	CbGdCrCtD
Tretinoin—CRABP1—trigeminal ganglion—peripheral nervous system neoplasm	0.00017	0.0615	CbGeAlD
Tretinoin—CRABP2—trigeminal ganglion—peripheral nervous system neoplasm	0.000153	0.0556	CbGeAlD
Tretinoin—CRABP1—brainstem—peripheral nervous system neoplasm	0.00015	0.0544	CbGeAlD
Tretinoin—CRABP2—parotid gland—peripheral nervous system neoplasm	0.000145	0.0524	CbGeAlD
Tretinoin—RXRG—trigeminal ganglion—peripheral nervous system neoplasm	0.000134	0.0486	CbGeAlD
Tretinoin—ALDH1A1—trigeminal ganglion—peripheral nervous system neoplasm	0.000128	0.0463	CbGeAlD
Tretinoin—ALDH1A1—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.000121	0.186	CbGdCrCtD
Tretinoin—ALDH1A1—parotid gland—peripheral nervous system neoplasm	0.000121	0.0437	CbGeAlD
Tretinoin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.000113	0.000588	CbGbCtD
Tretinoin—ALDH1A1—brainstem—peripheral nervous system neoplasm	0.000113	0.041	CbGeAlD
Tretinoin—RARG—trigeminal ganglion—peripheral nervous system neoplasm	0.000112	0.0406	CbGeAlD
Tretinoin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.000104	0.000539	CbGbCtD
Tretinoin—ALDH1A1—Idarubicin—Epirubicin—peripheral nervous system neoplasm	9.16e-05	0.141	CbGdCrCtD
Tretinoin—ALDH1A1—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	8.48e-05	0.131	CbGdCrCtD
Tretinoin—ALDH1A2—cerebellum—peripheral nervous system neoplasm	7.67e-05	0.0278	CbGeAlD
Tretinoin—CRABP1—cerebellum—peripheral nervous system neoplasm	7.4e-05	0.0268	CbGeAlD
Tretinoin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	7.08e-05	0.000367	CbGbCtD
Tretinoin—CRABP2—cerebellum—peripheral nervous system neoplasm	6.7e-05	0.0243	CbGeAlD
Tretinoin—RARB—cerebellum—peripheral nervous system neoplasm	5.99e-05	0.0217	CbGeAlD
Tretinoin—ALDH1A1—cerebellum—peripheral nervous system neoplasm	5.58e-05	0.0202	CbGeAlD
Tretinoin—RXRB—cerebellum—peripheral nervous system neoplasm	5.5e-05	0.0199	CbGeAlD
Tretinoin—RARG—cerebellum—peripheral nervous system neoplasm	4.89e-05	0.0177	CbGeAlD
Tretinoin—RARA—cerebellum—peripheral nervous system neoplasm	4.59e-05	0.0166	CbGeAlD
Tretinoin—CYP1A1—parotid gland—peripheral nervous system neoplasm	3.63e-05	0.0132	CbGeAlD
Tretinoin—CYP2A6—cerebellum—peripheral nervous system neoplasm	3.24e-05	0.0117	CbGeAlD
Tretinoin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	1.91e-05	0.00335	CbGpPWpGaD
Tretinoin—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—peripheral nervous system neoplasm	1.88e-05	0.0033	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—EED—peripheral nervous system neoplasm	1.84e-05	0.00324	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—EED—peripheral nervous system neoplasm	1.84e-05	0.00324	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—GNS—peripheral nervous system neoplasm	1.78e-05	0.00313	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—GNS—peripheral nervous system neoplasm	1.78e-05	0.00313	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—GNS—peripheral nervous system neoplasm	1.78e-05	0.00313	CbGpPWpGaD
Tretinoin—RXRA—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	1.76e-05	0.00309	CbGpPWpGaD
Tretinoin—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	1.74e-05	0.00306	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—CNTN6—peripheral nervous system neoplasm	1.72e-05	0.00302	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—SUZ12—peripheral nervous system neoplasm	1.71e-05	0.00301	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—NME1—peripheral nervous system neoplasm	1.71e-05	0.003	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—NME1—peripheral nervous system neoplasm	1.71e-05	0.003	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—NME1—peripheral nervous system neoplasm	1.71e-05	0.003	CbGpPWpGaD
Tretinoin—CYP4A11—NRF2 pathway—HGF—peripheral nervous system neoplasm	1.7e-05	0.00298	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.68e-05	0.00294	CbGpPWpGaD
Tretinoin—Alitretinoin—ABCB1—peripheral nervous system neoplasm	1.66e-05	1	CrCbGaD
Tretinoin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	1.66e-05	0.00292	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—COX2—peripheral nervous system neoplasm	1.64e-05	0.00289	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—COX2—peripheral nervous system neoplasm	1.64e-05	0.00289	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—COX2—peripheral nervous system neoplasm	1.64e-05	0.00289	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—SUZ12—peripheral nervous system neoplasm	1.57e-05	0.00275	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—SUZ12—peripheral nervous system neoplasm	1.53e-05	0.0027	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—SUZ12—peripheral nervous system neoplasm	1.47e-05	0.00259	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—SUZ12—peripheral nervous system neoplasm	1.47e-05	0.00259	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.39e-05	0.00245	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	1.36e-05	0.00239	CbGpPWpGaD
Tretinoin—RXRA—Retinoic acid receptors-mediated signaling—AKT1—peripheral nervous system neoplasm	1.35e-05	0.00238	CbGpPWpGaD
Tretinoin—RXRA—NRF2 pathway—HGF—peripheral nervous system neoplasm	1.35e-05	0.00237	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.25e-05	0.0022	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	1.24e-05	0.00218	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.22e-05	0.00214	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.2e-05	0.00211	CbGpPWpGaD
Tretinoin—CYP2A6—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	1.18e-05	0.00207	CbGpPWpGaD
Tretinoin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	1.15e-05	0.00202	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	1.14e-05	0.002	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.14e-05	0.002	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	1.12e-05	0.00197	CbGpPWpGaD
Tretinoin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—peripheral nervous system neoplasm	1.11e-05	0.00195	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.1e-05	0.00194	CbGpPWpGaD
Tretinoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	1.1e-05	0.00193	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.09e-05	0.00192	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.08e-05	0.0019	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—ENO2—peripheral nervous system neoplasm	1.08e-05	0.0019	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—ENO2—peripheral nervous system neoplasm	1.08e-05	0.0019	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.06e-05	0.00187	CbGpPWpGaD
Tretinoin—CYP2A6—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	9.96e-06	0.00175	CbGpPWpGaD
Tretinoin—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—peripheral nervous system neoplasm	9.78e-06	0.00172	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—EED—peripheral nervous system neoplasm	9.59e-06	0.00169	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.41e-06	0.00165	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—BCHE—peripheral nervous system neoplasm	9.12e-06	0.0016	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—BCHE—peripheral nervous system neoplasm	9.12e-06	0.0016	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—BCHE—peripheral nervous system neoplasm	9.12e-06	0.0016	CbGpPWpGaD
Tretinoin—CYP2A6—NRF2 pathway—HGF—peripheral nervous system neoplasm	9.04e-06	0.00159	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	8.88e-06	0.00156	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.7e-06	0.00153	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.7e-06	0.00153	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.7e-06	0.00153	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—TH—peripheral nervous system neoplasm	8.57e-06	0.00151	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—TH—peripheral nervous system neoplasm	8.57e-06	0.00151	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—TH—peripheral nervous system neoplasm	8.57e-06	0.00151	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	8.51e-06	0.0015	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	8.38e-06	0.00147	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—NCAM1—peripheral nervous system neoplasm	8.38e-06	0.00147	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.22e-06	0.00145	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.09e-06	0.00142	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.82e-06	0.00137	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	7.68e-06	0.00135	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—SUZ12—peripheral nervous system neoplasm	7.67e-06	0.00135	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.46e-06	0.00131	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	7.44e-06	0.00131	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.42e-06	0.0013	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	7.29e-06	0.00128	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—GNAS—peripheral nervous system neoplasm	7e-06	0.00123	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—GNAS—peripheral nervous system neoplasm	7e-06	0.00123	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—GNAS—peripheral nervous system neoplasm	7e-06	0.00123	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	6.99e-06	0.00123	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	6.93e-06	0.00122	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—ABCB1—peripheral nervous system neoplasm	6.87e-06	0.00121	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—ABCB1—peripheral nervous system neoplasm	6.87e-06	0.00121	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	6.87e-06	0.00121	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—GNS—peripheral nervous system neoplasm	6.8e-06	0.0012	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—NME1—peripheral nervous system neoplasm	6.52e-06	0.00115	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—COX2—peripheral nervous system neoplasm	6.28e-06	0.0011	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	6.26e-06	0.0011	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	6.25e-06	0.0011	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.2e-06	0.00109	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	6.16e-06	0.00108	CbGpPWpGaD
Tretinoin—NR0B1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	6.1e-06	0.00107	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.98e-06	0.00105	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—GNS—peripheral nervous system neoplasm	5.94e-06	0.00104	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.9e-06	0.00104	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.85e-06	0.00103	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—NME1—peripheral nervous system neoplasm	5.7e-06	0.001	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	5.68e-06	0.000999	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.62e-06	0.000989	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.53e-06	0.000971	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—COX2—peripheral nervous system neoplasm	5.49e-06	0.000964	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.47e-06	0.000961	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	5.44e-06	0.000957	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—GNS—peripheral nervous system neoplasm	5.39e-06	0.000948	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—NME1—peripheral nervous system neoplasm	5.17e-06	0.000909	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.07e-06	0.000891	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.01e-06	0.000881	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—COX2—peripheral nervous system neoplasm	4.98e-06	0.000875	CbGpPWpGaD
Tretinoin—RARG—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	4.92e-06	0.000864	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.52e-06	0.000795	CbGpPWpGaD
Tretinoin—RXRG—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	4.5e-06	0.00079	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.44e-06	0.00078	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	4.44e-06	0.00078	CbGpPWpGaD
Tretinoin—RARB—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	4.41e-06	0.000775	CbGpPWpGaD
Tretinoin—RARA—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	4.23e-06	0.000743	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	4.23e-06	0.000743	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.12e-06	0.000725	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—ENO2—peripheral nervous system neoplasm	4.12e-06	0.000724	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.04e-06	0.000711	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—MET—peripheral nervous system neoplasm	4e-06	0.000704	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GNS—peripheral nervous system neoplasm	3.95e-06	0.000695	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.95e-06	0.000694	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—NME1—peripheral nervous system neoplasm	3.79e-06	0.000666	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.73e-06	0.000656	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—PTPN11—peripheral nervous system neoplasm	3.7e-06	0.000651	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	3.65e-06	0.000641	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	3.64e-06	0.00064	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GNS—peripheral nervous system neoplasm	3.62e-06	0.000637	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ENO2—peripheral nervous system neoplasm	3.6e-06	0.000633	CbGpPWpGaD
Tretinoin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	3.54e-06	6.27e-05	CcSEcCtD
Tretinoin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	3.53e-06	6.26e-05	CcSEcCtD
Tretinoin—Weight increased—Epirubicin—peripheral nervous system neoplasm	3.53e-06	6.25e-05	CcSEcCtD
Tretinoin—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	3.52e-06	6.23e-05	CcSEcCtD
Tretinoin—Weight decreased—Epirubicin—peripheral nervous system neoplasm	3.51e-06	6.21e-05	CcSEcCtD
Tretinoin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	3.51e-06	6.21e-05	CcSEcCtD
Tretinoin—Somnolence—Etoposide—peripheral nervous system neoplasm	3.5e-06	6.2e-05	CcSEcCtD
Tretinoin—Asthenia—Vincristine—peripheral nervous system neoplasm	3.48e-06	6.17e-05	CcSEcCtD
Tretinoin—CYP4A11—Metabolism—BCHE—peripheral nervous system neoplasm	3.48e-06	0.000612	CbGpPWpGaD
Tretinoin—Pneumonia—Epirubicin—peripheral nervous system neoplasm	3.48e-06	6.16e-05	CcSEcCtD
Tretinoin—CYP2A6—Metabolism—NME1—peripheral nervous system neoplasm	3.47e-06	0.00061	CbGpPWpGaD
Tretinoin—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	3.46e-06	6.13e-05	CcSEcCtD
Tretinoin—Infestation—Epirubicin—peripheral nervous system neoplasm	3.46e-06	6.13e-05	CcSEcCtD
Tretinoin—Drowsiness—Epirubicin—peripheral nervous system neoplasm	3.46e-06	6.13e-05	CcSEcCtD
Tretinoin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	3.46e-06	6.12e-05	CcSEcCtD
Tretinoin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	3.45e-06	6.11e-05	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	3.43e-06	6.07e-05	CcSEcCtD
Tretinoin—Rash—Dactinomycin—peripheral nervous system neoplasm	3.43e-06	6.07e-05	CcSEcCtD
Tretinoin—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.42e-06	0.000602	CbGpPWpGaD
Tretinoin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	3.42e-06	6.06e-05	CcSEcCtD
Tretinoin—Renal failure—Epirubicin—peripheral nervous system neoplasm	3.4e-06	6.02e-05	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	3.4e-06	6.02e-05	CcSEcCtD
Tretinoin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	3.39e-06	6.01e-05	CcSEcCtD
Tretinoin—Fatigue—Etoposide—peripheral nervous system neoplasm	3.39e-06	6.01e-05	CcSEcCtD
Tretinoin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	3.39e-06	6e-05	CcSEcCtD
Tretinoin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	3.37e-06	5.97e-05	CcSEcCtD
Tretinoin—Pain—Etoposide—peripheral nervous system neoplasm	3.36e-06	5.96e-05	CcSEcCtD
Tretinoin—Constipation—Etoposide—peripheral nervous system neoplasm	3.36e-06	5.96e-05	CcSEcCtD
Tretinoin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	3.36e-06	5.95e-05	CcSEcCtD
Tretinoin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	3.36e-06	5.95e-05	CcSEcCtD
Tretinoin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	3.35e-06	5.94e-05	CcSEcCtD
Tretinoin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	3.35e-06	5.94e-05	CcSEcCtD
Tretinoin—CYP2A6—Metabolism—COX2—peripheral nervous system neoplasm	3.34e-06	0.000588	CbGpPWpGaD
Tretinoin—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	3.33e-06	5.91e-05	CcSEcCtD
Tretinoin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	3.33e-06	5.9e-05	CcSEcCtD
Tretinoin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	3.32e-06	5.89e-05	CcSEcCtD
Tretinoin—CYP4A11—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.32e-06	0.000584	CbGpPWpGaD
Tretinoin—Sweating—Epirubicin—peripheral nervous system neoplasm	3.31e-06	5.87e-05	CcSEcCtD
Tretinoin—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	3.31e-06	5.87e-05	CcSEcCtD
Tretinoin—Haematuria—Epirubicin—peripheral nervous system neoplasm	3.3e-06	5.84e-05	CcSEcCtD
Tretinoin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	3.27e-06	5.8e-05	CcSEcCtD
Tretinoin—CYP4A11—Metabolism—TH—peripheral nervous system neoplasm	3.27e-06	0.000575	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ENO2—peripheral nervous system neoplasm	3.27e-06	0.000574	CbGpPWpGaD
Tretinoin—Weight increased—Doxorubicin—peripheral nervous system neoplasm	3.27e-06	5.78e-05	CcSEcCtD
Tretinoin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	3.26e-06	5.78e-05	CcSEcCtD
Tretinoin—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	3.25e-06	5.75e-05	CcSEcCtD
Tretinoin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	3.24e-06	5.75e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	3.24e-06	5.74e-05	CcSEcCtD
Tretinoin—Nausea—Dactinomycin—peripheral nervous system neoplasm	3.23e-06	5.72e-05	CcSEcCtD
Tretinoin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	3.23e-06	5.72e-05	CcSEcCtD
Tretinoin—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	3.22e-06	5.7e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	3.22e-06	5.7e-05	CcSEcCtD
Tretinoin—Dizziness—Vincristine—peripheral nervous system neoplasm	3.21e-06	5.69e-05	CcSEcCtD
Tretinoin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	3.2e-06	5.68e-05	CcSEcCtD
Tretinoin—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	3.2e-06	5.67e-05	CcSEcCtD
Tretinoin—Infestation—Doxorubicin—peripheral nervous system neoplasm	3.2e-06	5.67e-05	CcSEcCtD
Tretinoin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	3.2e-06	5.67e-05	CcSEcCtD
Tretinoin—Rash—Alitretinoin—peripheral nervous system neoplasm	3.18e-06	5.63e-05	CcSEcCtD
Tretinoin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	3.17e-06	5.62e-05	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	3.17e-06	5.62e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	3.16e-06	5.6e-05	CcSEcCtD
Tretinoin—Headache—Alitretinoin—peripheral nervous system neoplasm	3.16e-06	5.59e-05	CcSEcCtD
Tretinoin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	3.14e-06	5.57e-05	CcSEcCtD
Tretinoin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	3.14e-06	5.56e-05	CcSEcCtD
Tretinoin—Urticaria—Etoposide—peripheral nervous system neoplasm	3.13e-06	5.54e-05	CcSEcCtD
Tretinoin—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	3.12e-06	5.53e-05	CcSEcCtD
Tretinoin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	3.12e-06	5.52e-05	CcSEcCtD
Tretinoin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	3.11e-06	5.51e-05	CcSEcCtD
Tretinoin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	3.11e-06	5.51e-05	CcSEcCtD
Tretinoin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	3.11e-06	5.51e-05	CcSEcCtD
Tretinoin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	3.11e-06	5.51e-05	CcSEcCtD
Tretinoin—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	3.1e-06	5.5e-05	CcSEcCtD
Tretinoin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	3.1e-06	5.5e-05	CcSEcCtD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.1e-06	0.000545	CbGpPWpGaD
Tretinoin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	3.09e-06	5.47e-05	CcSEcCtD
Tretinoin—Vomiting—Vincristine—peripheral nervous system neoplasm	3.09e-06	5.47e-05	CcSEcCtD
Tretinoin—Asthenia—Cisplatin—peripheral nervous system neoplasm	3.08e-06	5.46e-05	CcSEcCtD
Tretinoin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	3.08e-06	5.46e-05	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.08e-06	0.000541	CbGpPWpGaD
Tretinoin—Sweating—Doxorubicin—peripheral nervous system neoplasm	3.07e-06	5.43e-05	CcSEcCtD
Tretinoin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	3.07e-06	5.43e-05	CcSEcCtD
Tretinoin—Rash—Vincristine—peripheral nervous system neoplasm	3.06e-06	5.42e-05	CcSEcCtD
Tretinoin—Dermatitis—Vincristine—peripheral nervous system neoplasm	3.06e-06	5.42e-05	CcSEcCtD
Tretinoin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	3.06e-06	5.42e-05	CcSEcCtD
Tretinoin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	3.05e-06	5.4e-05	CcSEcCtD
Tretinoin—CYP2C18—Metabolism—BCHE—peripheral nervous system neoplasm	3.04e-06	0.000535	CbGpPWpGaD
Tretinoin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	3.04e-06	5.39e-05	CcSEcCtD
Tretinoin—Headache—Vincristine—peripheral nervous system neoplasm	3.04e-06	5.39e-05	CcSEcCtD
Tretinoin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	3.02e-06	5.35e-05	CcSEcCtD
Tretinoin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	3e-06	5.32e-05	CcSEcCtD
Tretinoin—Nausea—Alitretinoin—peripheral nervous system neoplasm	2.99e-06	5.3e-05	CcSEcCtD
Tretinoin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	2.99e-06	5.3e-05	CcSEcCtD
Tretinoin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	2.99e-06	5.29e-05	CcSEcCtD
Tretinoin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	2.94e-06	5.2e-05	CcSEcCtD
Tretinoin—NR0B1—Gene Expression—MYC—peripheral nervous system neoplasm	2.94e-06	0.000516	CbGpPWpGaD
Tretinoin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	2.93e-06	5.2e-05	CcSEcCtD
Tretinoin—RXRA—Developmental Biology—ERBB2—peripheral nervous system neoplasm	2.93e-06	0.000514	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	2.92e-06	0.000514	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.9e-06	0.00051	CbGpPWpGaD
Tretinoin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	2.9e-06	5.14e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	2.9e-06	5.13e-05	CcSEcCtD
Tretinoin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	2.89e-06	5.13e-05	CcSEcCtD
Tretinoin—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	2.89e-06	5.11e-05	CcSEcCtD
Tretinoin—Nausea—Vincristine—peripheral nervous system neoplasm	2.88e-06	5.11e-05	CcSEcCtD
Tretinoin—Flushing—Epirubicin—peripheral nervous system neoplasm	2.88e-06	5.1e-05	CcSEcCtD
Tretinoin—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	2.87e-06	5.09e-05	CcSEcCtD
Tretinoin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	2.87e-06	5.09e-05	CcSEcCtD
Tretinoin—CYP2C18—Metabolism—TH—peripheral nervous system neoplasm	2.86e-06	0.000503	CbGpPWpGaD
Tretinoin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	2.86e-06	5.06e-05	CcSEcCtD
Tretinoin—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	2.86e-06	0.000502	CbGpPWpGaD
Tretinoin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	2.85e-06	5.05e-05	CcSEcCtD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.84e-06	0.0005	CbGpPWpGaD
Tretinoin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	2.84e-06	5.02e-05	CcSEcCtD
Tretinoin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	2.83e-06	5.01e-05	CcSEcCtD
Tretinoin—Asthenia—Etoposide—peripheral nervous system neoplasm	2.82e-06	5e-05	CcSEcCtD
Tretinoin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	2.82e-06	4.99e-05	CcSEcCtD
Tretinoin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	2.82e-06	4.99e-05	CcSEcCtD
Tretinoin—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	2.8e-06	0.000492	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.78e-06	0.00049	CbGpPWpGaD
Tretinoin—Chills—Epirubicin—peripheral nervous system neoplasm	2.78e-06	4.93e-05	CcSEcCtD
Tretinoin—Pruritus—Etoposide—peripheral nervous system neoplasm	2.78e-06	4.93e-05	CcSEcCtD
Tretinoin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	2.77e-06	4.91e-05	CcSEcCtD
Tretinoin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	2.77e-06	4.9e-05	CcSEcCtD
Tretinoin—RXRA—Metabolism—BCHE—peripheral nervous system neoplasm	2.76e-06	0.000485	CbGpPWpGaD
Tretinoin—Alopecia—Epirubicin—peripheral nervous system neoplasm	2.74e-06	4.86e-05	CcSEcCtD
Tretinoin—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	2.74e-06	0.000481	CbGpPWpGaD
Tretinoin—Vomiting—Cisplatin—peripheral nervous system neoplasm	2.73e-06	4.84e-05	CcSEcCtD
Tretinoin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	2.72e-06	4.82e-05	CcSEcCtD
Tretinoin—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.72e-06	0.000478	CbGpPWpGaD
Tretinoin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	2.72e-06	4.81e-05	CcSEcCtD
Tretinoin—Rash—Cisplatin—peripheral nervous system neoplasm	2.71e-06	4.8e-05	CcSEcCtD
Tretinoin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	2.7e-06	4.79e-05	CcSEcCtD
Tretinoin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	2.7e-06	4.79e-05	CcSEcCtD
Tretinoin—Erythema—Epirubicin—peripheral nervous system neoplasm	2.7e-06	4.79e-05	CcSEcCtD
Tretinoin—CYP1A1—Metabolism—GNS—peripheral nervous system neoplasm	2.7e-06	0.000474	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	2.7e-06	0.000474	CbGpPWpGaD
Tretinoin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	2.69e-06	4.77e-05	CcSEcCtD
Tretinoin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	2.68e-06	4.75e-05	CcSEcCtD
Tretinoin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	2.68e-06	4.74e-05	CcSEcCtD
Tretinoin—CYP4A11—Metabolism—GNAS—peripheral nervous system neoplasm	2.67e-06	0.00047	CbGpPWpGaD
Tretinoin—Flushing—Doxorubicin—peripheral nervous system neoplasm	2.67e-06	4.72e-05	CcSEcCtD
Tretinoin—Flatulence—Epirubicin—peripheral nervous system neoplasm	2.66e-06	4.72e-05	CcSEcCtD
Tretinoin—Tension—Epirubicin—peripheral nervous system neoplasm	2.65e-06	4.7e-05	CcSEcCtD
Tretinoin—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	2.64e-06	0.000463	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.63e-06	0.000463	CbGpPWpGaD
Tretinoin—Nervousness—Epirubicin—peripheral nervous system neoplasm	2.62e-06	4.65e-05	CcSEcCtD
Tretinoin—CYP4A11—Metabolism—ABCB1—peripheral nervous system neoplasm	2.62e-06	0.000461	CbGpPWpGaD
Tretinoin—Back pain—Epirubicin—peripheral nervous system neoplasm	2.61e-06	4.63e-05	CcSEcCtD
Tretinoin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	2.61e-06	4.62e-05	CcSEcCtD
Tretinoin—Dizziness—Etoposide—peripheral nervous system neoplasm	2.6e-06	4.61e-05	CcSEcCtD
Tretinoin—RXRA—Metabolism—TH—peripheral nervous system neoplasm	2.6e-06	0.000456	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—NME1—peripheral nervous system neoplasm	2.59e-06	0.000455	CbGpPWpGaD
Tretinoin—Chills—Doxorubicin—peripheral nervous system neoplasm	2.58e-06	4.56e-05	CcSEcCtD
Tretinoin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	2.57e-06	4.54e-05	CcSEcCtD
Tretinoin—Nausea—Cisplatin—peripheral nervous system neoplasm	2.55e-06	4.52e-05	CcSEcCtD
Tretinoin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	2.55e-06	4.51e-05	CcSEcCtD
Tretinoin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	2.54e-06	4.5e-05	CcSEcCtD
Tretinoin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	2.52e-06	4.46e-05	CcSEcCtD
Tretinoin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	2.51e-06	4.44e-05	CcSEcCtD
Tretinoin—Vomiting—Etoposide—peripheral nervous system neoplasm	2.5e-06	4.43e-05	CcSEcCtD
Tretinoin—Erythema—Doxorubicin—peripheral nervous system neoplasm	2.5e-06	4.43e-05	CcSEcCtD
Tretinoin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	2.5e-06	4.43e-05	CcSEcCtD
Tretinoin—Anaemia—Epirubicin—peripheral nervous system neoplasm	2.5e-06	4.42e-05	CcSEcCtD
Tretinoin—CYP1A1—Metabolism—COX2—peripheral nervous system neoplasm	2.49e-06	0.000438	CbGpPWpGaD
Tretinoin—Agitation—Epirubicin—peripheral nervous system neoplasm	2.48e-06	4.4e-05	CcSEcCtD
Tretinoin—Rash—Etoposide—peripheral nervous system neoplasm	2.48e-06	4.39e-05	CcSEcCtD
Tretinoin—Dermatitis—Etoposide—peripheral nervous system neoplasm	2.48e-06	4.39e-05	CcSEcCtD
Tretinoin—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	2.47e-06	0.000435	CbGpPWpGaD
Tretinoin—Headache—Etoposide—peripheral nervous system neoplasm	2.46e-06	4.37e-05	CcSEcCtD
Tretinoin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	2.46e-06	4.36e-05	CcSEcCtD
Tretinoin—Tension—Doxorubicin—peripheral nervous system neoplasm	2.45e-06	4.35e-05	CcSEcCtD
Tretinoin—Malaise—Epirubicin—peripheral nervous system neoplasm	2.44e-06	4.32e-05	CcSEcCtD
Tretinoin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	2.43e-06	4.3e-05	CcSEcCtD
Tretinoin—Syncope—Epirubicin—peripheral nervous system neoplasm	2.42e-06	4.29e-05	CcSEcCtD
Tretinoin—Back pain—Doxorubicin—peripheral nervous system neoplasm	2.42e-06	4.28e-05	CcSEcCtD
Tretinoin—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	2.39e-06	0.000421	CbGpPWpGaD
Tretinoin—Palpitations—Epirubicin—peripheral nervous system neoplasm	2.39e-06	4.23e-05	CcSEcCtD
Tretinoin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	2.37e-06	4.21e-05	CcSEcCtD
Tretinoin—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	2.37e-06	0.000417	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—MYC—peripheral nervous system neoplasm	2.37e-06	0.000416	CbGpPWpGaD
Tretinoin—Cough—Epirubicin—peripheral nervous system neoplasm	2.36e-06	4.18e-05	CcSEcCtD
Tretinoin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	2.36e-06	4.17e-05	CcSEcCtD
Tretinoin—Convulsion—Epirubicin—peripheral nervous system neoplasm	2.34e-06	4.15e-05	CcSEcCtD
Tretinoin—Nausea—Etoposide—peripheral nervous system neoplasm	2.34e-06	4.14e-05	CcSEcCtD
Tretinoin—CYP2C18—Metabolism—GNAS—peripheral nervous system neoplasm	2.34e-06	0.000411	CbGpPWpGaD
Tretinoin—Hypertension—Epirubicin—peripheral nervous system neoplasm	2.33e-06	4.13e-05	CcSEcCtD
Tretinoin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	2.32e-06	4.11e-05	CcSEcCtD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.31e-06	0.000407	CbGpPWpGaD
Tretinoin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	2.31e-06	4.09e-05	CcSEcCtD
Tretinoin—Myalgia—Epirubicin—peripheral nervous system neoplasm	2.3e-06	4.08e-05	CcSEcCtD
Tretinoin—Chest pain—Epirubicin—peripheral nervous system neoplasm	2.3e-06	4.08e-05	CcSEcCtD
Tretinoin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	2.3e-06	4.08e-05	CcSEcCtD
Tretinoin—Agitation—Doxorubicin—peripheral nervous system neoplasm	2.3e-06	4.07e-05	CcSEcCtD
Tretinoin—Anxiety—Epirubicin—peripheral nervous system neoplasm	2.29e-06	4.06e-05	CcSEcCtD
Tretinoin—CYP2C18—Metabolism—ABCB1—peripheral nervous system neoplasm	2.29e-06	0.000403	CbGpPWpGaD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	2.28e-06	4.05e-05	CcSEcCtD
Tretinoin—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	2.28e-06	0.000401	CbGpPWpGaD
Tretinoin—Discomfort—Epirubicin—peripheral nervous system neoplasm	2.27e-06	4.03e-05	CcSEcCtD
Tretinoin—Malaise—Doxorubicin—peripheral nervous system neoplasm	2.25e-06	3.99e-05	CcSEcCtD
Tretinoin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	2.25e-06	3.99e-05	CcSEcCtD
Tretinoin—Syncope—Doxorubicin—peripheral nervous system neoplasm	2.24e-06	3.97e-05	CcSEcCtD
Tretinoin—RXRA—Developmental Biology—NRAS—peripheral nervous system neoplasm	2.23e-06	0.000391	CbGpPWpGaD
Tretinoin—Confusional state—Epirubicin—peripheral nervous system neoplasm	2.22e-06	3.94e-05	CcSEcCtD
Tretinoin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	2.21e-06	3.91e-05	CcSEcCtD
Tretinoin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	2.21e-06	3.91e-05	CcSEcCtD
Tretinoin—Oedema—Epirubicin—peripheral nervous system neoplasm	2.21e-06	3.91e-05	CcSEcCtD
Tretinoin—RXRA—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	2.2e-06	0.000387	CbGpPWpGaD
Tretinoin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	2.2e-06	3.89e-05	CcSEcCtD
Tretinoin—CYP2A6—Metabolism—ENO2—peripheral nervous system neoplasm	2.19e-06	0.000386	CbGpPWpGaD
Tretinoin—Infection—Epirubicin—peripheral nervous system neoplasm	2.19e-06	3.88e-05	CcSEcCtD
Tretinoin—Cough—Doxorubicin—peripheral nervous system neoplasm	2.18e-06	3.86e-05	CcSEcCtD
Tretinoin—Shock—Epirubicin—peripheral nervous system neoplasm	2.17e-06	3.84e-05	CcSEcCtD
Tretinoin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	2.17e-06	3.84e-05	CcSEcCtD
Tretinoin—RXRG—Gene Expression—MYC—peripheral nervous system neoplasm	2.16e-06	0.000381	CbGpPWpGaD
Tretinoin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	2.16e-06	3.83e-05	CcSEcCtD
Tretinoin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	2.16e-06	3.82e-05	CcSEcCtD
Tretinoin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	2.16e-06	3.82e-05	CcSEcCtD
Tretinoin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	2.15e-06	3.81e-05	CcSEcCtD
Tretinoin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	2.14e-06	3.79e-05	CcSEcCtD
Tretinoin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	2.13e-06	3.78e-05	CcSEcCtD
Tretinoin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	2.13e-06	3.77e-05	CcSEcCtD
Tretinoin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	2.13e-06	3.77e-05	CcSEcCtD
Tretinoin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	2.13e-06	3.77e-05	CcSEcCtD
Tretinoin—RARB—Gene Expression—MYC—peripheral nervous system neoplasm	2.12e-06	0.000373	CbGpPWpGaD
Tretinoin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	2.12e-06	3.76e-05	CcSEcCtD
Tretinoin—RXRA—Metabolism—GNAS—peripheral nervous system neoplasm	2.12e-06	0.000373	CbGpPWpGaD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	2.11e-06	3.74e-05	CcSEcCtD
Tretinoin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	2.1e-06	3.73e-05	CcSEcCtD
Tretinoin—Anorexia—Epirubicin—peripheral nervous system neoplasm	2.1e-06	3.72e-05	CcSEcCtD
Tretinoin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	2.08e-06	3.69e-05	CcSEcCtD
Tretinoin—RXRA—Metabolism—ABCB1—peripheral nervous system neoplasm	2.08e-06	0.000366	CbGpPWpGaD
Tretinoin—Hypotension—Epirubicin—peripheral nervous system neoplasm	2.06e-06	3.65e-05	CcSEcCtD
Tretinoin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	2.06e-06	3.64e-05	CcSEcCtD
Tretinoin—Oedema—Doxorubicin—peripheral nervous system neoplasm	2.04e-06	3.61e-05	CcSEcCtD
Tretinoin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	2.04e-06	3.61e-05	CcSEcCtD
Tretinoin—NR0B1—Gene Expression—AKT1—peripheral nervous system neoplasm	2.04e-06	0.000358	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—MYC—peripheral nervous system neoplasm	2.04e-06	0.000358	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—MYC—peripheral nervous system neoplasm	2.04e-06	0.000358	CbGpPWpGaD
Tretinoin—Infection—Doxorubicin—peripheral nervous system neoplasm	2.03e-06	3.59e-05	CcSEcCtD
Tretinoin—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	2.02e-06	0.000356	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	2.01e-06	0.000354	CbGpPWpGaD
Tretinoin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	2.01e-06	3.56e-05	CcSEcCtD
Tretinoin—Shock—Doxorubicin—peripheral nervous system neoplasm	2.01e-06	3.56e-05	CcSEcCtD
Tretinoin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	2e-06	3.54e-05	CcSEcCtD
Tretinoin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	2e-06	3.54e-05	CcSEcCtD
Tretinoin—Insomnia—Epirubicin—peripheral nervous system neoplasm	1.99e-06	3.53e-05	CcSEcCtD
Tretinoin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	1.99e-06	3.53e-05	CcSEcCtD
Tretinoin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	1.98e-06	3.51e-05	CcSEcCtD
Tretinoin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	1.98e-06	3.51e-05	CcSEcCtD
Tretinoin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	1.97e-06	3.49e-05	CcSEcCtD
Tretinoin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	1.97e-06	3.48e-05	CcSEcCtD
Tretinoin—Somnolence—Epirubicin—peripheral nervous system neoplasm	1.96e-06	3.47e-05	CcSEcCtD
Tretinoin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	1.94e-06	3.45e-05	CcSEcCtD
Tretinoin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	1.94e-06	3.44e-05	CcSEcCtD
Tretinoin—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.93e-06	0.000339	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.93e-06	0.000339	CbGpPWpGaD
Tretinoin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	1.92e-06	3.4e-05	CcSEcCtD
Tretinoin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	1.91e-06	3.38e-05	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	1.9e-06	3.37e-05	CcSEcCtD
Tretinoin—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	1.9e-06	0.000334	CbGpPWpGaD
Tretinoin—Fatigue—Epirubicin—peripheral nervous system neoplasm	1.9e-06	3.37e-05	CcSEcCtD
Tretinoin—ALDH1A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.89e-06	0.000332	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—AKT1—peripheral nervous system neoplasm	1.89e-06	0.000332	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—AKT1—peripheral nervous system neoplasm	1.89e-06	0.000332	CbGpPWpGaD
Tretinoin—Pain—Epirubicin—peripheral nervous system neoplasm	1.89e-06	3.34e-05	CcSEcCtD
Tretinoin—Constipation—Epirubicin—peripheral nervous system neoplasm	1.89e-06	3.34e-05	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	1.86e-06	3.29e-05	CcSEcCtD
Tretinoin—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.86e-06	0.000327	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—BCHE—peripheral nervous system neoplasm	1.85e-06	0.000326	CbGpPWpGaD
Tretinoin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	1.85e-06	3.27e-05	CcSEcCtD
Tretinoin—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.84e-06	0.000323	CbGpPWpGaD
Tretinoin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	1.83e-06	3.25e-05	CcSEcCtD
Tretinoin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	1.82e-06	3.22e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	1.82e-06	3.22e-05	CcSEcCtD
Tretinoin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	1.81e-06	3.21e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	1.8e-06	3.19e-05	CcSEcCtD
Tretinoin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	1.8e-06	3.18e-05	CcSEcCtD
Tretinoin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	1.77e-06	3.14e-05	CcSEcCtD
Tretinoin—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	1.77e-06	0.000311	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.77e-06	0.000311	CbGpPWpGaD
Tretinoin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	1.76e-06	3.12e-05	CcSEcCtD
Tretinoin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	1.76e-06	3.12e-05	CcSEcCtD
Tretinoin—Urticaria—Epirubicin—peripheral nervous system neoplasm	1.75e-06	3.1e-05	CcSEcCtD
Tretinoin—Constipation—Doxorubicin—peripheral nervous system neoplasm	1.74e-06	3.09e-05	CcSEcCtD
Tretinoin—Pain—Doxorubicin—peripheral nervous system neoplasm	1.74e-06	3.09e-05	CcSEcCtD
Tretinoin—CYP2A6—Metabolism—TH—peripheral nervous system neoplasm	1.74e-06	0.000306	CbGpPWpGaD
Tretinoin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	1.74e-06	3.09e-05	CcSEcCtD
Tretinoin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	1.74e-06	3.09e-05	CcSEcCtD
Tretinoin—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	1.73e-06	0.000304	CbGpPWpGaD
Tretinoin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	1.68e-06	2.98e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	1.67e-06	2.96e-05	CcSEcCtD
Tretinoin—RARG—Gene Expression—AKT1—peripheral nervous system neoplasm	1.64e-06	0.000289	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.63e-06	0.000287	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.63e-06	0.000286	CbGpPWpGaD
Tretinoin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	1.62e-06	2.88e-05	CcSEcCtD
Tretinoin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	1.62e-06	2.87e-05	CcSEcCtD
Tretinoin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	1.61e-06	2.86e-05	CcSEcCtD
Tretinoin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	1.61e-06	2.86e-05	CcSEcCtD
Tretinoin—Asthenia—Epirubicin—peripheral nervous system neoplasm	1.58e-06	2.8e-05	CcSEcCtD
Tretinoin—Pruritus—Epirubicin—peripheral nervous system neoplasm	1.56e-06	2.76e-05	CcSEcCtD
Tretinoin—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	1.55e-06	0.000273	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	1.52e-06	0.000268	CbGpPWpGaD
Tretinoin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	1.51e-06	2.67e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	1.5e-06	2.66e-05	CcSEcCtD
Tretinoin—RXRG—Gene Expression—AKT1—peripheral nervous system neoplasm	1.5e-06	0.000264	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	1.5e-06	0.000263	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	1.5e-06	0.000263	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—AKT1—peripheral nervous system neoplasm	1.47e-06	0.000259	CbGpPWpGaD
Tretinoin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	1.46e-06	2.59e-05	CcSEcCtD
Tretinoin—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	1.46e-06	0.000257	CbGpPWpGaD
Tretinoin—Dizziness—Epirubicin—peripheral nervous system neoplasm	1.46e-06	2.58e-05	CcSEcCtD
Tretinoin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	1.44e-06	2.56e-05	CcSEcCtD
Tretinoin—RXRA—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.44e-06	0.000253	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.43e-06	0.000251	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GNAS—peripheral nervous system neoplasm	1.42e-06	0.00025	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—AKT1—peripheral nervous system neoplasm	1.41e-06	0.000248	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—AKT1—peripheral nervous system neoplasm	1.41e-06	0.000248	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	1.41e-06	0.000247	CbGpPWpGaD
Tretinoin—Vomiting—Epirubicin—peripheral nervous system neoplasm	1.4e-06	2.48e-05	CcSEcCtD
Tretinoin—CYP2A6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.4e-06	0.000245	CbGpPWpGaD
Tretinoin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	1.4e-06	2.47e-05	CcSEcCtD
Tretinoin—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.39e-06	0.000245	CbGpPWpGaD
Tretinoin—Rash—Epirubicin—peripheral nervous system neoplasm	1.39e-06	2.46e-05	CcSEcCtD
Tretinoin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	1.39e-06	2.46e-05	CcSEcCtD
Tretinoin—CYP1A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.38e-06	0.000243	CbGpPWpGaD
Tretinoin—Headache—Epirubicin—peripheral nervous system neoplasm	1.38e-06	2.45e-05	CcSEcCtD
Tretinoin—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	1.37e-06	0.000242	CbGpPWpGaD
Tretinoin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	1.35e-06	2.39e-05	CcSEcCtD
Tretinoin—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.33e-06	0.000233	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.32e-06	0.000232	CbGpPWpGaD
Tretinoin—Nausea—Epirubicin—peripheral nervous system neoplasm	1.31e-06	2.32e-05	CcSEcCtD
Tretinoin—CYP1A1—Metabolism—TH—peripheral nervous system neoplasm	1.3e-06	0.000228	CbGpPWpGaD
Tretinoin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.3e-06	2.3e-05	CcSEcCtD
Tretinoin—Rash—Doxorubicin—peripheral nervous system neoplasm	1.29e-06	2.28e-05	CcSEcCtD
Tretinoin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.29e-06	2.28e-05	CcSEcCtD
Tretinoin—Headache—Doxorubicin—peripheral nervous system neoplasm	1.28e-06	2.26e-05	CcSEcCtD
Tretinoin—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.27e-06	0.000224	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	1.27e-06	0.000223	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.23e-06	0.000215	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	1.22e-06	0.000214	CbGpPWpGaD
Tretinoin—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.21e-06	2.15e-05	CcSEcCtD
Tretinoin—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.21e-06	0.000212	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	1.19e-06	0.000209	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	1.15e-06	0.000202	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.13e-06	0.000198	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	1.12e-06	0.000197	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	1.1e-06	0.000194	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MYC—peripheral nervous system neoplasm	1.06e-06	0.000186	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.06e-06	0.000186	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.04e-06	0.000183	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	1.03e-06	0.000181	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.83e-07	0.000173	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	9.72e-07	0.000171	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	9.69e-07	0.00017	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	9.54e-07	0.000168	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	8.05e-07	0.000141	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	7.91e-07	0.000139	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	7.76e-07	0.000136	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—AKT1—peripheral nervous system neoplasm	7.36e-07	0.000129	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—AKT1—peripheral nervous system neoplasm	7.21e-07	0.000127	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	6.8e-07	0.000119	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.48e-07	0.000114	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	6.39e-07	0.000112	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—AKT1—peripheral nervous system neoplasm	6.3e-07	0.000111	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—AKT1—peripheral nervous system neoplasm	5.72e-07	0.000101	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	5.22e-07	9.17e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	5.12e-07	9e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	4.19e-07	7.37e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AKT1—peripheral nervous system neoplasm	3.84e-07	6.75e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	3.1e-07	5.45e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	3.03e-07	5.33e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.86e-07	5.03e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	2.62e-07	4.61e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	2.14e-07	3.75e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.41e-07	2.48e-05	CbGpPWpGaD
